| Company: | Mindray Medical International Limited |
| Ticker Symbol: | MR |
| Class Period: | Jan-11-10 to Aug-9-10 |
| Date Filed: | Jul-27-11 |
| Lead Plaintiff Deadline: | Sep-25-11 |
| Court: | -- |
| Allegations: | |
It has been alleged that during the Class Period, Mindray and certain of its officers and directors made materially false and misleading statements or failed to disclose material information related to the company's business and operations in violation of the Securities Exchange Act of 1934. Specifically, it is alleged that the defendants misrepresented and/or failed to disclose the following adverse facts: (a) that Mindray was experiencing declining sales domestically due to the lack of Chinese government tenders and a slowdown in non-tender Chinese sales; (b) that Mindray's sales of its diagnostics and ultrasound equipment were not performing according to internal expectations; (c) that Mindray was confronting increased competition in the market for larger hospital systems in China; and (d) that, as a result of the foregoing, defendants lacked a reasonable basis for their positive statements about the Mindray and its prospects.
If you acquired the securities of the defendants during the Class Period you may, no later than the Lead Plaintiff Deadline shown above, request that the Court appoint you as lead plaintiff through counsel of your choice. You may also choose to remain an absent class member. A lead plaintiff must meet certain requirements.
